# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Gary Taylor maintains Molina Healthcare (NYSE:MOH) with a Buy and lowers the price target from $453 to $412.
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and lowers the price target fr...
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and lowers the price target from $437...
Stephens & Co. analyst Scott Fidel reiterates Molina Healthcare (NYSE:MOH) with a Equal-Weight and maintains $390 price ...
Molina Healthcare (NYSE:MOH) reported quarterly earnings of $5.73 per share which beat the analyst consensus estimate of $5.59 ...
Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Mo...